Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder.

Andrea Tubaro

首页> 外文期刊>current opinion in urology >Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder.

【24h】

Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder.

机译：Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder.

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相关主题

著录项

来源
《current opinion in urology》 |2000年第3期|261-262|共页
作者
Andrea Tubaro;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号

Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder.

著录项

相关主题

期刊订阅